Gil Bashe 
Think Bigger!
Historically, launching a healthcare brand has been a well-orchestrated affair. Every team prepared its ...
Looking at Consumers Through “Retro Glasses?”
Communication is always the heart of great patient care. Yet, the content that makes ...
Can Pharma Escape the Drug Pricing Policy Hammer?
While difficult to believe that Democrats and Republicans might now find common ground on ...
Make Science Powerful for the People
High science is a foundational element of marketing communications. Science enables us to express ...
Collaboration or Collision?
The thermometer became a go-to medical device in the 18th Century. But, in the ...
A New Age in Pricing
Medicines are the preferred path to arrest disease and restore health. And while scientists ...
Say Goodbye to FDA Complacency
Too many people think the Food and Drug Administration (FDA) favors predictability over speed. ...
Is it Invention or Innovation?
Words reflect intent. There was a time in the 1980s and early ’90s that ...
The Art of Indecision
Caution: We are entering a climate of uncertainty, where the natural response is a ...
From Obamacare to Trumpcare: America Readies for Change
The Affordable Care Act (ACA) has been a magnet for heated Beltway conversation since ...
Is the Consumer Still King?
Thirty years ago, medical marketing history was made with the launch of the first ...
Can the Shine be Restored to Pharma’s Tarnished Reputation Crown?
Hydro-fracturing (i.e., fracking) and tobacco have long endured societal disdain. Tolerating public abuse has ...
Reaffirmed ACA Shifts Business as Usual
Regardless of how health executives called the recent King v. Burwell coin toss, the ...
